Constipation Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Constipation stocks.

Constipation Stocks Recent News

Date Stock Title
Nov 20 MRK Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care
Nov 20 MRK Merck & Co., Inc. (MRK)’s Blockbuster Drugs: A Key Player in Ken Griffin’s Portfolio
Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
Nov 20 ARDX Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
Nov 19 MRK Merck readies new Keytruda version ahead of major regulatory headwinds
Nov 19 MRK Merck's Multi-Billion Dollar Drug Keytruda's Investigational Under The Skin Injection At Par With Intravenous Formulation In Untreated Lung Cancer Patients
Nov 19 ARDX High Growth Tech Stocks To Explore In November 2024
Nov 19 MRK Merck raises dividend to $0.81/share
Nov 19 MRK Merck Announces First-Quarter 2025 Dividend
Nov 19 MRK Merck: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
Nov 19 ABBV Where Will AbbVie Be in 5 Years?
Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
Nov 19 MRK Merck says injectable Keytruda succeeded in late-stage trial
Nov 19 MRK Under-the-skin Keytruda comparable to infused version in Phase 3 study, Merck says
Nov 19 MRK Merck Announces Phase 3 Trial of Subcutaneous Pembrolizumab With Berahyaluronidase Alfa Met Primary Endpoints
Nov 19 ABBV RVPH: Year-End OLE Update
Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
Nov 18 MRK Jim Cramer Says Merck & Co., Inc. (MRK) Is ‘Just Way Too Hated’
Nov 18 ABBV AbbVie snaps eight straight sessions of losses
Nov 18 NKTR Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence
Constipation

Constipation refers to bowel movements that are infrequent or hard to pass. The stool is often hard and dry. Other symptoms may include abdominal pain, bloating, and feeling as if one has not completely passed the bowel movement. Complications from constipation may include hemorrhoids, anal fissure or fecal impaction. The normal frequency of bowel movements in adults is between three per day and three per week. Babies often have three to four bowel movements per day while young children typically have two to three per day.Constipation has many causes. Common causes include slow movement of stool within the colon, irritable bowel syndrome, and pelvic floor disorders. Underlying associated diseases include hypothyroidism, diabetes, Parkinson's disease, celiac disease, non-celiac gluten sensitivity, colon cancer, diverticulitis, and inflammatory bowel disease. Medications associated with constipation include opioids, certain antacids, calcium channel blockers, and anticholinergics. Of those taking opioids about 90% develop constipation. Constipation is more concerning when there is weight loss or anemia, blood is present in the stool, there is a history of inflammatory bowel disease or colon cancer in a person's family, or it is of new onset in someone who is older.Treatment of constipation depends on the underlying cause and the duration that it has been present. Measures that may help include drinking enough fluids, eating more fiber, and exercise. If this is not effective, laxatives of the bulk forming agent, osmotic agent, stool softener, or lubricant type may be recommended. Stimulant laxatives are generally reserved for when other types are not effective. Other treatments may include biofeedback or in rare cases surgery.In the general population rates of constipation are 2–30 percent. Among elderly people living in a care home the rate of constipation is 50–75 percent. People spend, in the United States, more than US$250 million on medications for constipation a year.

Browse All Tags